Docusign Inc. (NASDAQ:DOCU – Get Free Report) CEO Allan Thygesen sold 26,250 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total transaction of $1,208,025.00. Following the completion of the sale, the chief executive officer owned 159,038 shares of the company’s stock, valued at approximately $7,318,928.76. This trade represents a 14.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Trading Down 0.5%
NASDAQ DOCU opened at $45.77 on Friday. The firm’s fifty day simple moving average is $46.89 and its two-hundred day simple moving average is $50.93. The firm has a market capitalization of $8.74 billion, a P/E ratio of 29.72, a P/E/G ratio of 1.36 and a beta of 0.90. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $86.65.
Docusign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The firm had revenue of $830.24 million during the quarter, compared to analyst estimates of $824.71 million. During the same quarter in the prior year, the business posted $0.90 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts predict that Docusign Inc. will post 2.03 earnings per share for the current fiscal year.
Docusign News Summary
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Zacks boosted longer-term earnings expectations for DocuSign, including higher FY2027, FY2028, and future quarterly EPS estimates, which suggests improving profitability over time.
- Positive Sentiment: DocuSign highlighted its AI assistant and agents at Momentum London 2026, signaling ongoing product innovation and an effort to strengthen its platform in the AI-driven workflow market. Docusign showcases AI assistant and agents at Momentum London 2026 to power the next era of agreement work
- Neutral Sentiment: DocuSign is also being pitched by Zacks as a long-term value idea, reflecting a favorable valuation case rather than a clear near-term catalyst. Why DocuSign (DOCU) is a Top Value Stock for the Long-Term
- Negative Sentiment: Multiple executives, including CEO Allan C. Thygesen, CFO Blake Jeffrey Grayson, and CRO Paula Hansen, sold shares under pre-arranged 10b5-1 plans, which can weigh on investor sentiment even if the sales were planned.
- Negative Sentiment: Paula Hansen’s additional 6,000-share sale was separately reported again this morning, keeping insider selling in focus for traders. Paula Hansen Sells 6,000 Shares of Docusign (NASDAQ:DOCU) Stock
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of DOCU. Central Pacific Bank Trust Division acquired a new stake in shares of Docusign during the fourth quarter worth about $25,000. Modus Advisors LLC acquired a new position in Docusign in the 4th quarter worth approximately $27,000. Torren Management LLC acquired a new position in Docusign in the 4th quarter worth approximately $28,000. Aventura Private Wealth LLC purchased a new position in Docusign during the 4th quarter worth approximately $30,000. Finally, True Wealth Design LLC raised its position in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after buying an additional 222 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the stock. Citigroup upped their price objective on shares of Docusign from $50.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, June 5th. JPMorgan Chase & Co. lowered their target price on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Piper Sandler dropped their target price on shares of Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 18th. Wall Street Zen upgraded shares of Docusign from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 13th. Finally, UBS Group set a $60.00 price target on shares of Docusign in a report on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $60.27.
Get Our Latest Stock Analysis on DOCU
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Recommended Stories
- Five stocks we like better than Docusign
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
